End-of-day quote
BURSA MALAYSIA
06:00:00 2024-06-04 pm EDT
|
5-day change
|
1st Jan Change
|
3.2
MYR
|
+0.63%
|
|
-0.31%
|
+18.52%
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
15,488
|
23,279
|
30,669
|
16,575
|
6,493
|
10,922
|
-
|
-
|
Enterprise Value (EV)
1 |
15,682
|
23,248
|
28,343
|
14,435
|
4,918
|
9,386
|
9,220
|
9,258
|
P/E ratio
|
34.2
x
|
53.6
x
|
10.6
x
|
5.12
x
|
-29.8
x
|
743
x
|
52.2
x
|
32.7
x
|
Yield
|
1.86%
|
1.08%
|
1.98%
|
11.8%
|
-
|
0.22%
|
0.85%
|
1.62%
|
Capitalization / Revenue
|
5.48
x
|
7.96
x
|
4.58
x
|
2.1
x
|
2.7
x
|
5.11
x
|
4.04
x
|
3.44
x
|
EV / Revenue
|
5.55
x
|
7.95
x
|
4.23
x
|
1.83
x
|
2.04
x
|
5.11
x
|
3.41
x
|
2.91
x
|
EV / EBITDA
|
23.2
x
|
32.3
x
|
7.19
x
|
3.06
x
|
14.3
x
|
52.6
x
|
25.8
x
|
17
x
|
EV / FCF
|
26
x
|
57
x
|
10.4
x
|
5.02
x
|
-14.3
x
|
57.1
x
|
50.6
x
|
38.4
x
|
FCF Yield
|
3.84%
|
1.75%
|
9.62%
|
19.9%
|
-7.02%
|
1.75%
|
1.98%
|
2.61%
|
Price to Book
|
6.79
x
|
9.11
x
|
6.16
x
|
3.23
x
|
1.4
x
|
2.33
x
|
2.28
x
|
2.2
x
|
Nbr of stocks (in thousands)
|
3,345,187
|
3,383,613
|
3,434,324
|
3,417,462
|
3,417,462
|
3,413,262
|
-
|
-
|
Reference price
2 |
4.630
|
6.880
|
8.930
|
4.850
|
1.900
|
3.200
|
3.200
|
3.200
|
Announcement Date
|
5/7/19
|
5/18/20
|
5/4/21
|
5/10/22
|
5/9/23
|
5/21/24
|
-
|
-
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
2,828
|
2,924
|
6,696
|
7,888
|
2,408
|
1,838
|
2,704
|
3,179
|
EBITDA
1 |
675.6
|
720.5
|
3,942
|
4,722
|
344
|
176.3
|
358
|
543.1
|
EBIT
1 |
572
|
595.4
|
3,804
|
4,570
|
180.8
|
13.96
|
224.3
|
420.1
|
Operating Margin
|
20.23%
|
20.36%
|
56.82%
|
57.94%
|
7.51%
|
0.71%
|
8.3%
|
13.22%
|
Earnings before Tax (EBT)
1 |
551.9
|
556.3
|
3,813
|
4,637
|
-190.7
|
38.73
|
258.3
|
387.6
|
Net income
1 |
456.2
|
434.8
|
2,885
|
3,235
|
-218
|
12.72
|
204.1
|
310
|
Net margin
|
16.13%
|
14.87%
|
43.09%
|
41.01%
|
-9.06%
|
0.69%
|
7.55%
|
9.75%
|
EPS
2 |
0.1353
|
0.1284
|
0.8443
|
0.9464
|
-0.0638
|
0.003700
|
0.0613
|
0.0977
|
Free Cash Flow
1 |
602.1
|
407.7
|
2,727
|
2,874
|
-345.1
|
162.6
|
182.3
|
241.3
|
FCF margin
|
21.29%
|
13.94%
|
40.72%
|
36.44%
|
-14.33%
|
8.25%
|
6.74%
|
7.59%
|
FCF Conversion (EBITDA)
|
89.11%
|
56.59%
|
69.18%
|
60.86%
|
-
|
92.23%
|
50.92%
|
44.43%
|
FCF Conversion (Net income)
|
131.98%
|
93.77%
|
94.51%
|
88.86%
|
-
|
328.57%
|
89.3%
|
77.83%
|
Dividend per Share
2 |
0.0860
|
0.0740
|
0.1770
|
0.5700
|
-
|
0.007110
|
0.0273
|
0.0517
|
Announcement Date
|
5/7/19
|
5/18/20
|
5/4/21
|
5/10/22
|
5/9/23
|
5/21/24
|
-
|
-
|
Fiscal Period: March |
2023 Q1
|
2023 Q4
|
---|
Net sales
1 |
-
|
515.7
|
EBITDA
|
-
|
-
|
EBIT
|
-
|
-
|
Operating Margin
|
-
|
-
|
Earnings before Tax (EBT)
|
-
|
-
|
Net income
|
88.28
|
-
|
Net margin
|
-
|
-
|
EPS
2 |
0.0258
|
-0.0886
|
Dividend per Share
|
-
|
-
|
Announcement Date
|
8/9/22
|
5/9/23
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
194
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
31
|
2,326
|
2,139
|
1,575
|
1,641
|
1,703
|
1,664
|
Leverage (Debt/EBITDA)
|
0.2867
x
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
602
|
408
|
2,727
|
2,874
|
-345
|
163
|
182
|
241
|
ROE (net income / shareholders' equity)
|
21.5%
|
18.1%
|
63%
|
64.1%
|
-3.74%
|
0.9%
|
3.83%
|
6.93%
|
ROA (Net income/ Total Assets)
|
16.2%
|
13.8%
|
45.1%
|
49%
|
-4.46%
|
0.87%
|
3.68%
|
5.53%
|
Assets
1 |
2,812
|
3,155
|
6,399
|
6,607
|
4,889
|
5,710
|
5,545
|
5,607
|
Book Value Per Share
2 |
0.6800
|
0.7600
|
1.450
|
1.500
|
1.360
|
1.380
|
1.400
|
1.450
|
Cash Flow per Share
2 |
0.1900
|
0.1900
|
0.9000
|
1.090
|
-0.0100
|
0.0900
|
0.1400
|
0.1400
|
Capex
1 |
431
|
251
|
361
|
847
|
307
|
161
|
187
|
234
|
Capex / Sales
|
15.24%
|
8.59%
|
5.39%
|
10.73%
|
12.75%
|
8.18%
|
6.93%
|
7.36%
|
Announcement Date
|
5/7/19
|
5/18/20
|
5/4/21
|
5/10/22
|
5/9/23
|
5/21/24
|
-
|
-
|
Average target price
3.28
MYR Spread / Average Target +2.52% Consensus |
1st Jan change
|
Capi.
|
---|
| +18.52% | 2.33B | | +7.72% | 26.8B | | -40.87% | 2.66B | | -21.64% | 2.35B | | +9.29% | 2.28B | | -16.70% | 1.76B | | +15.56% | 1.77B | | +23.05% | 1.3B | | -2.32% | 1.25B | | +22.70% | 1.23B |
Medical Supplies
|